Cuban researchers highlighted the positive results of the national anti-Covid-19 vaccines as booster of other formulations, on the occasion of the beginning today of the administration of Soberana Plus to health personnel.
Holguín shows a better epidemiological scenario; however, this is the province with the highest report of cases confirmed in the country and the one that contributes the highest number of deaths, with a fatality rate above one percent.
The development of a novel formulation of recombinant human erythropoietin (NeuroEpo) by the Center for Molecular Immunology, in collaboration with others, offers hope in the treatment of this devastating illness.
The province of Holguín has included new population groups to the anti-COVID-19 vaccination programs, as part of the extension of immunization among the priorities of the public health sector in Cuba.